Documents | EPAD

Name	Downloads	Version	Owner	Last Modified	Rating
Name	Downloads	Version	Owner	Last Modified	Rating
Publications
Application of the ATN classification scheme in a population without dementia: Findings from the EPAD cohort » Application of the ATN classification scheme in a population without dementia Findings from the EPAD cohort.pdf File Options Download Description Preview Other Versions Goto Post	279 downloads	1.1	EPAD Administrator3	06-04-2021
Assessing and disclosing test results for ‘mild cognitive impairment’ the perspective of old age psychiatrists in Scotland » Assessing and disclosing test results for mild cognitive impairment - the perspective of old age psychiatrists in Scotland.pdf File Options Download Description Preview Other Versions Goto Post	14 downloads	1.0	EPAD Administrator3	17-01-2022
Associations Between Multimorbidity and Cerebrospinal Fluid Amyloid: A Cross-Sectional Analysis of the European Prevention of Alzheimer’s Dementia (EPAD) V500.0 Cohort » Multimorbidity and Cerebrospinal Fluid Amyloid_2019.pdf File Options Download Description Preview Other Versions Goto Post	708 downloads	1.1	EPAD Administrator3	16-08-2019
At, with and beyond risk: expectations of living with the possibility of future dementia » At with and beyond risk_2018.pdf File Options Download Description Preview Other Versions Goto Post	990 downloads	1.1	EPAD Administrator3	16-04-2018
Brain Amyloid Pathology and Cognitive Function Alzheimer Disease Without Dementia? » jama_2017.pdf File Options Download Description Preview Other Versions Goto Post	1543 downloads	1.0.1	EPAD Administrator3	13-06-2017
Cognitive Dispersion is not Associated with Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Results from the European Prevention of Alzheimer’s Dementia (EPAD) v500.0 Cohort » Cognitive_dispersion_2020.pdf File Options Download Description Preview Other Versions Goto Post	378 downloads	1.1	EPAD Administrator3	11-09-2020
Cognitive Functions as Predictors of Alzheimer’s Disease Biomarker Status in the European Prevention of Alzheimer’s Dementia Cohort » Cognive functions as predictor of ALzheimers disease 2020.pdf File Options Download Description Preview Other Versions Goto Post	560 downloads	1.1	EPAD Administrator3	05-03-2020
Detecting cognitive changes in preclinical Alzheimer's disease: A review of its feasibility » Detective cognitive changes in preclinal AD.pdf File Options Download Description Preview Other Versions Goto Post	1750 downloads	1.1		01-10-2016
Development of interventions for the secondary prevention of Alzheimer’s dementia: the European Prevention of Alzheimer’s Dementia (EPAD) project » abstractlancetpaper2015.pdf File Options Download Description Preview Other Versions Goto Post	1680 downloads	1.0		09-12-2015
Disease Modelling of Cognitive Outcomes and Biomarkers in the European Prevention of Alzheimer’s Dementia Longitudinal Cohort » Disease modelling of cognitive outcomes and biomarkers in the European Prevention of Alzheimer's Dementia Longitudinal Cohort.pdf File Options Download Description Preview Other Versions Goto Post	111 downloads	1.0	EPAD Administrator3	20-08-2021
Ethical Arguments Concerning the Use of Alzheimer's Disease Biomarkers in Individuals with No or Mild Cognitive Impairment: A Systematic Review and Framework for Discussion » Ethical_arguments_2018.pdf File Options Download Description Preview Other Versions Goto Post	703 downloads	1.1	EPAD Administrator3	12-12-2018
Ethical challenges in preclinical Alzheimer's disease observational studies and trials: Results of the Barcelona summit » abstract_ethical_challenges_2016.pdf File Options Download Description Preview Other Versions Goto Post	1287 downloads	1.0	EPAD Administrator3	15-03-2016
Ethical issues in the development of readiness cohorts in Alzheimer’s disease research » abstract_ethical_issues_2017.pdf File Options Download Description Preview Other Versions Goto Post	1362 downloads	1.0	EPAD Administrator3	22-02-2017
European Prevention of Alzheimer's Dementia Registry: Recruitment and prescreening approach for a longitudinal cohort and prevention trials » EPAD_Registry_2018.pdf File Options Download Description Preview Other Versions Goto Post	897 downloads	1.1	EPAD Administrator3	28-03-2018
European Prevention of Alzheimer’s Dementia Longitudinal Cohort Study (EPAD LCS): study protocol » EPAD LCS Study Protocol 2018.pdf File Options Download Description Preview Other Versions Goto Post	915 downloads	1.0	EPAD Administrator3	27-12-2018
Evaluating the Alzheimer's disease data landscape » Evaluating the Alzheimer disease data landscape.pdf File Options Download Description Preview Other Versions Goto Post	276 downloads	1.0	EPAD Administrator3	16-12-2020
Evolution and future directions for the concept of mild cognitive impairment » evolution_future_directions_2017.pdf File Options Download Description Preview Other Versions Goto Post	988 downloads	1.0	EPAD Administrator3	13-12-2017
Involving research participants in a pan-European research initiative: the EPAD participant panel experience » EPAD resaearhc particpant panel 2020.pdf File Options Download Description Preview Other Versions Goto Post	297 downloads	1.1	EPAD Administrator3	27-10-2020
Lived time and the affordances of clinical research participation » Lived time and the affordances of clinical research participation.pdf File Options Download Description Preview Other Versions Goto Post	16 downloads	1.0	EPAD Administrator3	14-01-2022
Medial temporal lobe atrophy and posterior atrophy scales normative values » Medical_temporal_2019.pdf File Options Download Description Preview Other Versions Goto Post	608 downloads	1.0	EPAD Administrator3	15-07-2019
Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in Alzheimer's disease » Multi study validation_2019.pdf File Options Download Description Preview Other Versions Goto Post	618 downloads	1.0	EPAD Administrator3	23-07-2019
On the personal utility of Alzheimer’s disease-related biomarker testing in the research context » Personal utility of Alzheimer’s disease-related biomarker testing in the research context.pdf File Options Download Description Preview Other Versions Goto Post	912 downloads	1.0	EPAD Administrator3	29-08-2018
Perspectives on Communicating Biomarker-Based Assessments of Alzheimer’s Disease to Cognitively Healthy Individuals » Biomarker_2018.pdf File Options Download Description Preview Other Versions Goto Post	841 downloads	1.0	EPAD Administrator3	20-02-2018
Precision prevention of Alzheimer's and other dementias: Anticipating future needs in the control of risk factors and implementation of disease‐modifying therapies » Precise prevention of Alzheimer's and other dementias 2020.pdf File Options Download Description Preview Other Versions Goto Post	318 downloads	1.0	EPAD Administrator3	20-08-2020
Prediction of Alzheimer’s disease biomarker status defined by the ‘ATN framework’ among cognitively healthy individuals: results from the EPAD longitudinal cohort study » Prediction of Alzheimer’s disease biomarker status defined by the ‘ATN framework’ among cognitively healthy individuals1.pdf File Options Download Description Preview Other Versions Goto Post	334 downloads	1.0	EPAD Administrator3	09-11-2020
Prescreening for European Prevention of Alzheimer Dementia (EPAD) trial-ready cohort: impact of AD risk factors and recruitment settings » Prescreening for EPAD trial-ready cohort_2020.pdf File Options Download Description Preview Other Versions Goto Post	534 downloads	1.0	EPAD Administrator3	06-01-2020
Psychological, behavioral and social effects of disclosing Alzheimer’s disease biomarkers to research participants: a systematic review » abstractrichardreview2016.pdf File Options Download Description Preview Other Versions Goto Post	1380 downloads	1.0		10-11-2016
Re-aligning scientific and lay narratives of Alzheimer's disease » Re-aligning scientific and lay narratives of Alzheimer's disease_2019.pdf File Options Download Description Preview Other Versions Goto Post	521 downloads	1.0	EPAD Administrator3	01-10-2019
Recommended cognitive outcomes in preclinical Alzheimer's disease: Consensus statement from the European Prevention of Alzheimer's Dementia project » Recommended cognitive outcomes in preclinical Alzheimer’s disease.pdf File Options Download Description Preview Other Versions Goto Post	1600 downloads	1.1		01-10-2016
Research participants as collaborators: Background, experience and policies from the PREVENT Dementia and EPAD programmes » Research participants as collaborators_2018.pdf File Options Download Description Preview Other Versions Goto Post	867 downloads	1.1	EPAD Administrator3	29-10-2018
Secondary prevention of Alzheimer’s dementia: neuroimaging contributions » Secondary prevention_2018.pdf File Options Download Description Preview Other Versions Goto Post	849 downloads	1.0	EPAD Administrator3	30-10-2018
The European Prevention of Alzheimer’s Dementia (EPAD) Longitudinal Cohort Study: Baseline Data Release V500.0 » v500.0_baseline data release_2019.pdf File Options Download Description Preview Other Versions Goto Post	565 downloads	1.0	EPAD Administrator3	26-11-2019
The influence of diversity on the measurement of functional impairment: An international validation of the Amsterdam IADL Questionnaire in eight countries » The influence of diversity 2020.pdf File Options Download Description Preview Other Versions Goto Post	248 downloads	1.0	EPAD Administrator3	13-05-2020
The Rationale Behind the New Alzheimer’s Disease Conceptualization: Lessons Learned During the Last Decades » Rationale_Behind_New_Alzheimer's_Disease_Conceptualization_2018.pdf File Options Download Description Preview Other Versions Goto Post	875 downloads	1.0	EPAD Administrator3	13-03-2018
The relation between APOE genotype and cerebral microbleeds in cognitively unimpaired middle- and old-aged individuals » The relation between APOE- 2020.pdf File Options Download Description Preview Other Versions Goto Post	254 downloads	1.0	EPAD Administrator3	30-11-2020
“Ready for What” Timing and Speculation in Alzheimer’s Disease Drug Development » “Ready for What” Timing and Speculation in Alzheimer’s Disease Drug Development.pdf File Options Download Description Preview Other Versions Goto Post	124 downloads	1.0	EPAD Administrator3	22-04-2021

EPAD

@IMI_EPAD

New paper in BMC Geriatrics reporting findings of qualitative research with senior Psychiatrists in Scotland conducted as part of an on-going longitudinal study assessing the impact of being disclosed of having #mildcognitiveimpairment @craig_ritchie68 bmcgeriatr.biomedcentral.com/…

1:06 pm · 2022-01-17

EPAD

@IMI_EPAD

Interested about the affordances of clinical research participation and the motivations in clinical research? Check out the below article, authors draw upon interviews with participants in the @IMI_EPAD study⤵️ onlinelibrary.wiley.com/doi/1…

10:05 am · 2022-01-14

EPAD

@IMI_EPAD

.@IMI_AMYPAD has developed a Europe-wide collaborative framework, establishing close collaborations with several study initiatives and parent cohorts, such as @IMI_EPAD, @IMI_EMIF-AD, ALFA+, and others. ➡️amypad.eu twitter.com/IMI_AMYPAD/sta…

9:19 am · 2022-01-12

EPAD

@IMI_EPAD

The @IMI_EPAD data are available in the @AlzData #ADWorkbench to provide even greater value to the global neuroscience research community. The @IMI_EPAD samples can also be requested for use in #Alzheimer’s prevention research. For more info, visit: ep-ad.org pic.twitter.com/EKpmAKZnyL

9:01 am · 2022-01-05

EPAD

@IMI_EPAD

The @IMI_EPAD samples can be requested for use in #Alzheimer’s prevention research. We can offer ☑️access to more than 100,000 samples ☑️from 2,094 participants with all associated data collected at annual visits ☑️originating at 31 study sites across EU ep-ad.org/samples-access/ pic.twitter.com/PiNBr6m5NT

8:45 am · 2021-12-20